7:10am ET
Investing
The 6 Most Shorted Dow Stocks
As of the most recently reported period, short sellers favored Apple, Microsoft and Intel above all other Dow stocks.
Companies
/Healthcare
Merck & Co Inc
$150.54
▼ $2.56 (−1.67%) today
Markets open · 3:33pm ET
MRK Coverage
Page 18
10:40am ET
Health and Healthcare
Why These 3 Biotechs More Than Doubled on Monday
Monday was a breakout day for a few biotech companies. Some made absolutely massive runs, practically doubling and then some. The biotechnology sector is pushing near all-time highs, and a few of…
9:00am ET
Health and Healthcare
Big Pharma Short Sellers Hike Their Bets
The November 15 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.
10:50am ET
Investing
How Dow 28,000 Can Rapidly Become Dow 30,000 and Even Higher in 2020
Despite the never-ending election cycle, there actually is a clear path for the Dow to hit 30,000 as soon as early 2020, if only a few things come to fruition. There does…
8:50am ET
Health and Healthcare
Big Pharma Scares Off Short Sellers
The October 31 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased.
11:20am ET
Investing
As the Dow Hits All-Time High, Over Half of Dow Stocks Keep Disappointing Investors
With markets at all-time highs, it's important to consider the winners and losers. In this case, many stocks in the Dow are still holding the index back from even stronger gains.
10:20am ET
Health and Healthcare
Is This the Turnaround Pfizer and Merck Shareholders Have Been Waiting For?
Shares of Merck and Pfizer both got boosts after they reported their most recent quarterly results before the opening bell Tuesday.
1:25pm ET
Health and Healthcare
Merck and Pfizer Earnings: What to Expect
Merck and Pfizer are set to report their most recent quarterly results before the opening bell tomorrow. Pfizer is one of the most shorted of all Dow stocks.
6:50am ET
Investing
Apple, Chevron, Exxon, Pfizer and More Dow Earnings Coming This Week
Six of the 30 Dow Jones industrial average components are scheduled to report their latest quarterly reports this week.
9:59am ET
Health and Healthcare
Short Sellers Can’t Make Up Their Minds on Big Pharma
The October 15 short interest data have been compared with the previous figures, and short interest moves in these selected pharmaceutical stocks were mixed.
6:45am ET
Health and Healthcare
How Biotech and Big Pharma Have Upside Heading Into Earnings
Credit Suisse and Merrill Lynch made calls in the biotech and pharmaceutical space last week, ahead of coming earnings reports.
9:15am ET
Investing
Top Analyst Upgrades and Downgrades: Abbott Labs, CSX, IBM, Netflix, Occidental, Whiting, Amgen, Gilead, Merck, Pfizer and More
Thursday's top analyst upgrades, downgrades and initiations included Abbott Laboratories, CSX, IBM, Netflix, Occidental Petroleum, Whiting Petroleum, Amgen, Gilead Sciences, Merck and Pfizer.
9:40am ET
Health and Healthcare
Big Pharma Sees Rising Tide in Short Interest
The September 30 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.
10:30am ET
Health and Healthcare
FDA Accepts for Review the Newest Treatment for C Diff
Merck has just announced that the FDA has accepted a couple new drug applications for review, including for a treatment for Clostridium difficile infections in children.
Chris Lange 10:45am ET
Health and Healthcare
Why Dividend-Paying Large-Cap Pharmaceuticals Could Shine in Q4
These four top large-cap pharmaceutical stocks for investors to consider all pay solid dividends and look like very solid fourth-quarter ideas.
